Emilie Desodt - Genfit Executive Resources
| GNFT Stock | USD 3.44 0.06 1.71% |
Executive
Emilie Desodt is Executive Resources of Genfit
| Age | 41 |
| Address | Parc EurasantE, Loos, France, 59120 |
| Phone | 33 3 20 16 40 00 |
| Web | https://www.genfit.com |
Genfit Management Efficiency
The company has return on total asset (ROA) of (0.0991) % which means that it has lost $0.0991 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (0.3557) %, meaning that it created substantial loss on money invested by shareholders. Genfit's management efficiency ratios could be used to measure how well Genfit manages its routine affairs as well as how well it operates its assets and liabilities. Return On Tangible Assets is likely to drop to -0.24 in 2024. Return On Capital Employed is likely to drop to -0.28 in 2024. Total Current Liabilities is likely to drop to about 24.2 M in 2024. Liabilities And Stockholders Equity is likely to drop to about 135.4 M in 2024Similar Executives
| Showing other executives | EXECUTIVE Age | ||
| Larry Soll | Invesco Trust For | 75 | |
| Chirfi Guindo | Merck Company | 58 | |
| Raymond Stickel | Invesco Trust For | 75 | |
| Tim OReilly | Invesco Trust For | N/A | |
| Peter Dannenbaum | Merck Company | N/A | |
| Suzanne Woolsey | Invesco Trust For | 77 | |
| Dalton III | Merck Company | 57 | |
| Steven Brunker | LSI Industries | N/A | |
| James Sferra | LSI Industries | 77 | |
| Joseph Romanelli | Merck Company | N/A | |
| James Lovelace | American Funds 2025 | N/A | |
| Crissie Wisdom | Invesco Trust For | 51 | |
| Joerg Koglin | Merck Company | N/A | |
| Rodney Dammeyer | Invesco Trust For | 77 | |
| Prema MathaiDavis | Invesco Trust For | 70 | |
| James Phillips | Invesco Trust For | N/A | |
| Jordan Krugman | Invesco Trust For | N/A | |
| Jack Fields | Invesco Trust For | 68 | |
| Hugo Sonnenschein | Invesco Trust For | 77 | |
| Thomas Caneris | LSI Industries | 61 | |
| David Arch | Invesco Trust For | 75 | |
Management Performance
| Return On Equity | -0.36 | ||||
| Return On Asset | -0.0991 |
Genfit Leadership Team
Elected by the shareholders, the Genfit's board of directors comprises two types of representatives: Genfit inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Genfit. The board's role is to monitor Genfit's management team and ensure that shareholders' interests are well served. Genfit's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Genfit's outside directors are responsible for providing unbiased perspectives on the board's policies.
| Stefanie JD, Chief Affairs | ||
| Pascal Caisey, Chief Officer | ||
| Dean Hum, COO, Chief Scientific Officer, Member of the Management Board | ||
| Thomas Baetz, Chief Officer | ||
| Charles Woler, Vice Chairman of the Supervisory Board | ||
| Pr Staels, CoFounder Board | ||
| JeanChristophe Marcoux, Chief Officer | ||
| Meriam Kabbaj, Chief Officer | ||
| Pascal Prigent, Chief Officer | ||
| Frederic Desdouits, Member of the Supervisory Board | ||
| Laurent Lannoo, Corporate Affairs | ||
| Bart Staels, President of the Scientific Advisory Board, Member of the Management Board | ||
| Xavier Buttes, Chairman of the Supervisory Board | ||
| JeanFrancois Mouney, Chairman of the Management Board, CEO | ||
| John Brozek, Executive Technology | ||
| Stefanie Magner, Chief Affairs | ||
| Florence Sejourne, Member of the Supervisory Board, Representative of Biotech Avenir | ||
| Emilie Desodt, Executive Resources | ||
| Nathalie Huitorel, Executive Vice President of Finance, Member of the Management Board | ||
| Philippe Moons, Member of the Supervisory Board, Representative of Finorpa |
Genfit Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Genfit a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Equity | -0.36 | ||||
| Return On Asset | -0.0991 | ||||
| Profit Margin | (0.84) % | ||||
| Operating Margin | (0.56) % | ||||
| Current Valuation | 166.39 M | ||||
| Shares Outstanding | 49.86 M | ||||
| Shares Owned By Institutions | 1.29 % | ||||
| Number Of Shares Shorted | 93.36 K | ||||
| Price To Earning | 4.72 X | ||||
| Price To Book | 2.45 X |
Building efficient market-beating portfolios requires time, education, and a lot of computing power!
The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.
Try AI Portfolio ArchitectCheck out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in Genfit. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in census. For more information on how to buy Genfit Stock please use our How to Invest in Genfit guide.Note that the Genfit information on this page should be used as a complementary analysis to other Genfit's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Investing Opportunities module to build portfolios using our predefined set of ideas and optimize them against your investing preferences.
Complementary Tools for Genfit Stock analysis
When running Genfit's price analysis, check to measure Genfit's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Genfit is operating at the current time. Most of Genfit's value examination focuses on studying past and present price action to predict the probability of Genfit's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Genfit's price. Additionally, you may evaluate how the addition of Genfit to your portfolios can decrease your overall portfolio volatility.
| Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Insider Screener Find insiders across different sectors to evaluate their impact on performance | |
| Fundamental Analysis View fundamental data based on most recent published financial statements | |
| Portfolio Analyzer Portfolio analysis module that provides access to portfolio diagnostics and optimization engine | |
| Portfolio Manager State of the art Portfolio Manager to monitor and improve performance of your invested capital | |
| Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Stock Tickers Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites |
Is Genfit's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Genfit. If investors know Genfit will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Genfit listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (0.62) | Revenue Per Share 0.694 | Quarterly Revenue Growth 0.373 | Return On Assets (0.1) | Return On Equity (0.36) |
The market value of Genfit is measured differently than its book value, which is the value of Genfit that is recorded on the company's balance sheet. Investors also form their own opinion of Genfit's value that differs from its market value or its book value, called intrinsic value, which is Genfit's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Genfit's market value can be influenced by many factors that don't directly affect Genfit's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Genfit's value and its price as these two are different measures arrived at by different means. Investors typically determine if Genfit is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Genfit's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.